摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

癸酸银 | 13126-67-5

中文名称
癸酸银
中文别名
——
英文名称
silver decanoate
英文别名
decanoic acid ; silver decanate;Decansaeure; Silberdecanoat;Decansaeure; Silbercaprinat;silver;decanoate
癸酸银化学式
CAS
13126-67-5
化学式
Ag*C10H19O2
mdl
——
分子量
279.128
InChiKey
OIZSSBDNMBMYFL-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    240.54 °C
  • 密度:
    1.18 g/cm3

计算性质

  • 辛醇/水分配系数(LogP):
    1.87
  • 重原子数:
    13
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.9
  • 拓扑面积:
    40.1
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2915900090

SDS

SDS:1e639717c0121921ca7b620531dc9350
查看
Name: Silver decanoate Material Safety Data Sheet
Synonym:
CAS: 13126-67-5
Section 1 - Chemical Product MSDS Name:Silver decanoate Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
13126-67-5 Silver decanoate 100.0 unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
No information regarding eye irritation and other potential effects was found.
Skin:
No information regarding skin irritation and other potential effects was found.
Ingestion:
The toxicological properties of this substance have not been fully investigated.
Inhalation:
The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use agent most appropriate to extinguish fire.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. Avoid generating dusty conditions.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 13126-67-5: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: cream
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 200 deg C
Solubility in water: Insoluble.
Specific Gravity/Density:
Molecular Formula: C10H19O2Ag
Molecular Weight: 279

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stability unknown.
Conditions to Avoid:
Incompatible materials, dust generation.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Not known.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 13126-67-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Silver decanoate - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Products which are considered hazardous for supply are classified as Special Waste and the disposal of such chemicals is covered by regulations which may vary according to location. Contact a specialist disposal company or the local waste regulator for advice. Empty containers must be decontaminated before returning for recycling.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 13126-67-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 13126-67-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 13126-67-5 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    癸酸银正己醇 作用下, 以 further solvent(s) 为溶剂, 生成
    参考文献:
    名称:
    Microwave-assisted Preparation of Silver Nanoparticles
    摘要:
    我们成功地通过微波辐射(2.45 GHz)下1到5分钟内,在413至430 K的温度下,用醇类还原脂肪酸银盐制备了银(Ag)纳米颗粒。只需改变脂肪酸中烷基链的长度,就能将Ag纳米颗粒的平均尺寸控制在4.9到7.4纳米之间。
    DOI:
    10.1246/cl.2004.158
  • 作为产物:
    描述:
    sodium decanoatesilver nitrate 为溶剂, 生成 癸酸银
    参考文献:
    名称:
    Microwave-assisted Preparation of Silver Nanoparticles
    摘要:
    我们成功地通过微波辐射(2.45 GHz)下1到5分钟内,在413至430 K的温度下,用醇类还原脂肪酸银盐制备了银(Ag)纳米颗粒。只需改变脂肪酸中烷基链的长度,就能将Ag纳米颗粒的平均尺寸控制在4.9到7.4纳米之间。
    DOI:
    10.1246/cl.2004.158
  • 作为试剂:
    描述:
    正癸酸 、 、 silver nitrate 、 在 Azanium;silver 、 癸酸银乙酸丁酯异丙醇 、 polyvinyl butyral 作用下, 以 乙酸丁酯 为溶剂, 反应 0.01h, 生成 癸酸银
    参考文献:
    名称:
    Heat developable light-sensitive material
    摘要:
    一种热显影光敏材料,包括支撑物和至少一层涂层,其中涂层含有至少(a)有机银盐、(b)光敏银卤化物或银卤化物形成组分和(c)还原剂,以及(d)铁系化合物,至少存在于支撑物的一层中。
    公开号:
    US04128428A1
点击查看最新优质反应信息

文献信息

  • Structural, odd–even chain alternation and thermal investigation of a homologous series of anhydrous silver(i) n-alkanoates
    作者:Peter Nattaniel Nelson、Henry Anthony Ellis
    DOI:10.1039/c2dt11638c
    日期:——
    are nearly isostructural, odd–even chain alternation is observed in density, anti-symmetric stretching vibrations of methyl and unusually, carboxylate (head) groups, as a result of packing differences of hydrocarbon chains within the crystal lattice. These arise from the relative vertical distances between polymeric sheets, which are not in the same plane. Thus, for odd chain length compounds, where
    从X射线粉末衍射,固态自旋解耦13 C-NMR和可变温度傅立叶变换红外光谱法确定(I)n-链烷酸酯的同源系列(n c = 8–20,包括Nc)的分子和晶格结构。这些化合物在单斜晶体系统中结晶,该链具有完全延伸的全反式构象的烃链。此外,链条大约倾斜。相对于属基面为75°,在层状结构中以甲基(尾)-甲基(尾)双层形式排列。来自双层中不同层的甲基链末端不重叠,但如此接近以引起甲基-甲基相互作用。在一个分子中,两个羧酸根基团以顺式-顺式结合型将双齿模式桥接至两个原子以形成八元结构。分子内的-和分子间的Ag-O-Ag相互作用稳定了头基并促进了层状聚合物片的形成。尽管这些化合物几乎是同构的,但由于晶格内烃链的堆积差异,在甲基,不寻常的羧酸根(头部)基团的密度,反对称拉伸振动中观察到了奇偶链交替。这些是由不在同一平面上的聚合物片之间的相对垂直距离引起的。因此,对于奇数链长的化合物,其中这些距离
  • Platinum(II) carboxylato complexes containing 7-azaindoles as N-donor carrier ligands showed cytotoxicity against cancer cell lines
    作者:Pavel Štarha、Zdeněk Trávníček、Lucia Pazderová、Zdeněk Dvořák
    DOI:10.1016/j.jinorgbio.2016.06.018
    日期:2016.9
    4 and 5). The representative complexes 2 and 4 showed mutually different effect on the A2780 cell cycle at IC50 concentrations after 24 h exposure. Concretely, the complex 2 caused cell cycle arrest at G0/G1 phase, while 4 induced cell death by apoptosis with high population of cells in sub-G1 cell cycle phase. The hydrolysis and interactions of the selected complexes with biomolecules (glutathione
    通式的(II)丙二酸(MAL)和decanoato(分解)络合物[PT(MAL)(Ñ氮杂)2 ](1 - 3)和顺式- [PT(分解)2(Ñ氮杂)2 ] (4 - 7)中制备,其特征在于和它们的测试在体外对细胞毒性顺铂敏感的(A2780)和顺铂抗性(A2780R)人卵巢癌细胞系和非癌的人肺成纤维细胞(MRC-5); n aza = 7-氮杂吲哚的卤代衍生物。配合物1 – 7有效克服卵巢癌细胞对顺铂的获得性抵抗。复合物2( 针对A2780的IC 50 = 26.6±8.9μM和针对A2780R的28.9±6.7μM),4(复合物(针对A2780的IC 50  = 14.5±0.6μM和针对A2780R的14.5±3.8μM)和5(IC 50  = 13.0± 1.1μM对A2780的抗性和对A2780R的13.6±4.9μM)表明对健康的MRC-5细胞毒性降低(IC 50  > 2分别为50
  • Detailed Study of C−O and C−C Bond-Forming Reductive Elimination from Stable C<sub>2</sub>N<sub>2</sub>O<sub>2</sub>−Ligated Palladium(IV) Complexes
    作者:Joy M. Racowski、Allison R. Dick、Melanie S. Sanford
    DOI:10.1021/ja9014474
    日期:2009.8.12
    This paper describes the synthesis of a series of Pd(IV) complexes of general structure (N~C)(2)Pd(IV)(O(2)CR)(2) (N~C = a rigid cyclometalated ligand; O(2)CR = carboxylate) by reaction of (N~C)(2)Pd(II) with PhI(O(2)CR)(2). The majority of these complexes undergo clean C-O bond-forming reductive elimination, and the mechanism of this process has been investigated. A variety of experiments, including
    本文描述了一系列具有一般结构 (N~C)(2)Pd(IV)(O(2)CR)(2) 的 Pd(IV) 配合物的合成(N~C = 刚性环属化配体;O (2)CR = 羧酸盐) 通过 (N~C)(2)Pd(II) 与 PhI(O(2)CR)(2) 的反应。这些配合物中的大多数都经历了清洁的 CO 键形成还原消除,并且已经研究了该过程的机制。各种实验,包括哈米特图、艾林分析、交叉研究以及溶剂和添加剂影响的研究,表明形成 CO 键的还原消除是通过初始羧酸盐解离然后从 5 配位阳离子 Pd( IV) 中间体。
  • Hydrates of Organic Compounds. VIII. The Effect of Carboxylate Anions on the Formation of Clathrate Hydrates of Tetrabutylammonium Carboxylates
    作者:Haruo Nakayama、Shigeru Torigata
    DOI:10.1246/bcsj.57.171
    日期:1984.1
    clathrate-like hydrates. The results can be summarized as follows: (1) for 14 carboxylates the formation of a clathrate-like hydrate is newly confirmed; (2) judging from melting points and hydration numbers, the hydrates can be classified into three groups: I, II, and III; (3) the group I hydrates, formed by the carboxylates with R=H, CH3, C2H5, n-C3H7, i-C3H7, and t-C4H9, have hydration numbers around
    检查了四丁基羧酸 (n-C4H9)4 NOOCR(R=Hn-C10H21,包括被甲基或乙基取代的各种烷基)与的二元混合物的固液相图,以确认形成笼状合物。结果可概括如下: (1) 14 种羧酸盐形成了笼形合物;(2)从熔点和合数判断,合物可分为I、II、III三类;(3) 由 R=H、CH3C2H5、n-C3H7、i- 和 t- 的羧酸盐形成的 I 组合物的合数约为 30,是本研究中最稳定的合物实验,除了 2-甲基丙酸酯和 2,2-二甲基丙酸合物;(4) II组合物,合数约为 39,由 R=n- 、s- 、i- 和所有 C5H11 的盐形成,并且相对不稳定(mp=5–11 °C);(5) III 组合物,...
  • Organic tellurium compounds—VIII
    作者:M. Moura Campos、E.L. Suranyi、H. de Andrade、N. Petragnani
    DOI:10.1016/s0040-4020(01)98497-2
    日期:1964.1
    di-p-tolyltelluride with ferric, cupric and mercuric chloride, performed in glacial acetic acid, effects the reduction of the metallic salts giving rise to di-p-tolyltellurium dichloride. In toluene solution only the ferric chloride was reduced and the anhydride of di-p-tolyltellurium hydroxychloride formed, due to the hydrolysis of the tellurium dichloride. The reaction of the mentioned telluride and benzoyl
    冰醋酸中进行二对甲苯基与三价的反应,使属盐还原,从而生成二化二对甲苯基。在甲苯溶液中,由于二氯化碲解,仅还原了,形成了二对甲苯基的酸酐。所述化物和苯甲酰氯的反应产生二化物和二苯甲酸酯的混合物。讨论了该反应的机理。
查看更多